News
24
2026-04
BrosMed Announced CE MDR Approval of Eagle™ Coronary Guidewire
Eagle™ workhorse coronary guidewire delivers excellent performance for routine PCI procedures.
2026-04-24
05
2026-03
BrosMed Medical Announces CE MDR Approval of Introducer Sheath Set
Advanced vascular access solution meets EU's stringent new regulatory standards, enabling commercial launch across European markets
2026-03-05
09
2025-09
09
2025-09
28
2025-04
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-28
12
2025-02
On February 10, BrosMed and Cordis signed an agreement for the exclusive distribution of VaSecure™, BrosMed’s next-generation drug-coated peripheral balloon catheter in the China market.
2025-02-12
07
2025-01
BrosMed Medical Obtains CE Mark for RevoEdge™ High-Pressure Cutting Balloon
BrosMed Medical is excited to announce that it has obtained CE mark for the RevoEdge High-Pressure Coronary Cutting Balloon under the European Medical Device Regulation (MDR). Redefining the standards of cutting balloons, this cutting-edge device is designed to offer unparalleled cutting performance and crossability.
2025-01-07
01
2024-08
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
